Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference

Go back to Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference

Tarsus Pharmaceuticals (TARS) PT Raised to $63 at BofA Securities

May 10, 2024 5:24 AM EDT

BofA Securities analyst Jason Gerberry raised the price target on Tarsus Pharmaceuticals (NASDAQ: TARS) to $63.00 (from $60.00) while maintaining a Buy rating.

The analyst comments "Tarsus reported strong 1Q results with sales of Xdemvy (demodex blepharitis) meaningfully outperforming expectations ($25m vs. $17m cons).... More